Female Infertility

Yen & Jaffe's Reproductive Endocrinology

Volumn , Issue , 2009, Pages 517-546

  Barbieri, Robert L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884017518     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4907-4.00021-8     Document Type: Chapter

References (323)

1. Stephen E.H., Chandra A. Declining estimates of infertility in the United States: 1982-2002. Fertil Steril 2006, 86:516.
2. Brosens I., Gordts S., Valkenburg M., et al. Investigation of the infertile couple: when is the appropriate time to explore female infertility?. Hum Reprod 2004, 19:1689.
3. Gnoth C., Godehardt D., Godehardt E., et al. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum Reprod 2003, 18:1959.
4. Hunault C.C., Habbema J.D.F., Eijkemans M.J.C., et al. Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Human Reprod 2004, 19:2019.
5. Cramer D.W., Walker A.M., Schiff I. Statistical methods in evaluating the outcome of infertility therapy. Fertil Steril 1979, 32:80.
6. Guttmacher A.F. Factors affecting normal expectancy of conception. JAMA 1956, 161:855.
7. Zinaman M.J., Clegg E.D., Brown C.C., et al. Estimates of human fertility and pregnancy loss. Fertil Steril 1996, 65:503.
8. Wilcox A.J., Weinburg C.R., O'Connor J., et al. Incidence of early loss of pregnancy. N Engl J Med 1988, 319:189.
9. Bloch S.K. Occult pregnancy: a pilot study. Obstet Gynecol 1976, 48:365.
10. WHO Technical Report Series Recent Advances in Medically Assisted Conception. Number 1992, 820:1-111.
11. Collins J.A. Unexplained infertility. Infertility: Evaluation and Treatment 1995, 249-262. WB Saunders, Philadelphia. W.R. Keye, R.J. Chang, R.W. Rebar, M.R. Soules (Eds.).
12. Smith S., Pfeifer S.M., Collins J.A. Diagnosis and management of female infertility. JAMA 2003, 290:1767.
13. Rice J.P., London S.N., Olive D.L. Reevaluation of hysterosalpingography in infertility investigation. Obstet Gynecol 1986, 67:718.
14. Glatstein I.Z., Best C.L., Palumbo A., et al. The reproducibility of the postcoital test. Obstet Gynecol 1995, 85:396.
15. Griffiths C.S., Grimes D.A. The validity of the postcoital test. Am J Obstet Gynecol 1990, 162:615.
16. Oei S.G., Helmerhorst F.M., Bloemenkamp K.W., et al. Effectiveness of the postcoital test: randomized controlled trial. BMJ 1998, 317:502.
17. Coutifaris C., Myers E.R., Guzick D.S., et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 2004, 82:1264.
18. Malcolm C.E., Cumming D.C. Does anovulation exist in eumenorrheic women?. Obstet Gynecol 2003, 102:317.
19. Wilcox A.J., Weinberg C.R., Baird D.D. Timing of sexual intercourse in relation to ovulation. N Engl J Med 1995, 333:1517.
20. Filicori M., Butler J.P., Crowley W.F. Neuroendocrine regulation of the corpus luteum in the human: evidence for pulsatile progesterone secretion. J Clin Invest 1984, 73:1638.
21. Hull M.G., Savage P.E., Bromham D.R., et al. The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle derived from treated and untreated conception cycles. Fertil Steril 1982, 37:355.
22. Lessey B.A., Castlebaum A.J., Sawin S.W., et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994, 79:643.
23. Hamilton C.J., Wetzels L.C., Evers J.L., et al. Follicle growth curves and hormonal patterns in patients with the luteinized unruptured follicle syndrome. Fertil Steril 1985, 43:541.
24. Kerin J.F., Kirby C., Morris D., et al. Incidence of the luteinized unruptured follicle phenomenon in cycling women. Fertil Steril 1983, 40:620.
25. Scheenjes E., te Velde E.R., Kremer J. Inspection of the ovaries and steroids in serum and peritoneal fluid at various time intervals after ovulation in fertile women: implications for the luteinized unruptured follicle syndrome. Fertil Steril 1990, 54:38.
26. Behre H.M., Kuhlage J., Gabner C., et al. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod 2000, 15:2478.
27. McGovern P.G., Myers E.R., Silva S., et al. Absence of secretory endometrium after false-positive home urine luteinizing hormone testing. Fertil Steril 2004, 82:1273.
28. Reindollar R.H., Novak M., Tho S.P.T., McDonough P.G. Adult onset amenorrhea: a study of 262 patients. Am J Obstet Gynecol 1986, 155:531.
29. Laufer M.R., Floor A.E., Parsons K.E., et al. Hormone testing in women with adult onset amenorrhea. Gynecol Obstet Invest 1995, 40:200.
30. Barbieri R.L., Ryan K.J. The menstrual cycle. Kistner's Gynecology: Principles and Practice 1995, 11-49. Mosby, St Louis. K.J. Ryan, R.S. Berkowitz, R.L. Barbieri (Eds.).
31. Collins J.A., Wrixon W., Janes L.B., Wilson E.H. Treatment independent pregnancy among infertile couples. N Engl J Med 1983, 309:1202.
32. Frisch R.E. The right weight: body fat, menarche and ovulation. Baillieres Clin Obstet Gynecol 1990, 4:419.
33. Grodstein F., Goldman M.B., Cramer D.W. Body mass index and ovulatory infertility. Epidemiology 1994, 5:247.
34. The ESHRE Capri Workshop Group. Nutrition and reproduction in women. Hum Reprod Update 2006, 12:193.
35. Pasquali R., Antenucci D., Casimirri E. Clinical and hormonal characteristics of obese and amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989, 68:173.
36. Clark A.M., Ledger W., Galletly C., et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995, 10:2705.
37. Guzick D.S., Wing R., Smith D., et al. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 1994, 61:598.
38. Loucks A.B., Thuma J.R. Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab 2003, 88:297.
39. Schneider J.S., Snow R.C., Barbieri R.L. High dietary fiber and low saturated fat intake among oligomenorrheic undergraduates. Fertil Steril 1990, 54:632.
40. Snow R., Barbieri R.L., Frisch R.A. Estrogen 2-hydroxylase activity and menstrual function in elite oarsmen. J Clin Endocrinol Metab 1989, 69:369.
41. Bates G.W., Bates S.R., Whitworth N.S. Reproductive failure in women who practice weight control. Fertil Steril 1982, 37:373.
42. Berga S., Marcus M.D., Loucks T.L., et al. Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy. Fertil Steril 2003, 80:976.
43. Kouba S., Hallstrom T., Lindholm C., Hirschberg A.L. Pregnancy and neonatal outcomes in women with eating disorders. Obstet Gynecol 2005, 105:255.
44. Chavarro J.E., Rich-Edwards J.W., Rosner B.A., Willett W.C. Iron intake and risk of ovulatory infertility. Obstet Gynecol 2006, 108:1145.
45. Chavarro J.E., Rich-Edwards J.W., Rosner B.A., Willett W.C. Diet and lifestyle in the prevention of ovulatory disorder infertility. Obstet Gynecol 2007, 110:1050.
46. Greenblatt R.B., Barfield W.E., Jungck E.C., Ray A.W. Induction of ovulation with MRL-41. JAMA 1961, 178:101.
47. Steiner A.Z., Terplan M., Paulson R.J. Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis. Hum Reprod 2005, 20:1511.
48. Kerin J.F., Liu J.H., Phillipou G., Yen S.S.C. Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab 1985, 61:265.
49. Kettel L.M., Roseff S.J., Berga S.L., et al. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril 1993, 59:532.
50. Jones G.S., Moraes-Ruehsen M. Induction of ovulation with human gonadotropins and with clomiphene. Fertil Steril 1965, 16:461.
51. Vaitukaitis J.L., Bermudez J.A., Cargille C.M., et al. New evidence for an antiestrogenic action of clomiphene citrate in women. J Clin Endocrinol Metab 1971, 32:503.
52. Tobias A., Carr L.A., Voogt J.L. Effects of estradiol benzoate and clomiphene on tyrosine hydroxylase activity and on luteinizing hormone and prolactin levels in ovariectomized rat. Life Sci 1981, 29:711.
53. Miyake A., Tasaka K., Sakumoto T., et al. Clomiphene citrate induces luteinizing hormone release through hypothalamic luteinizing hormone releasing hormone in vitro. Acta Endocrinol 1983, 103:289.
54. Adashi E.Y., Hsueh A.J., Bambino T.H., Yen S.S.C. Disparate effect of clomiphene and tamoxifen on pituitary gonadotropin release in vitro. Am J Physiol 1981, 240:E125.
55. Zhuang L., Adashi E.Y., Hsueh A.J. Direct enhancement of gonadotropin-stimulated ovarian estrogen biosynthesis by estrogen and clomiphene citrate. Endocrinology 1982, 110:2219.
56. Adashi E.Y. Clomiphene citrate initiated ovulation: a clinical update. Semin Reprod Endocrinol 1986, 4:255.
57. Pildes R.B. Induction of ovulation with clomiphene. Am J Obstet Gynecol 1965, 91:466.
58. Van Campenhout J., Simard R., Leduc B. Antiestrogenic effect of clomiphene in the human being. Fertil Steril 1968, 19:700.
59. WHO Scientific Group Report Consultation on the diagnosis and treatment of endocrine forms of female infertility. Tech Rep Series, No 1976, 514.
60. Hull M.G., Knuth U.A., Murray M.A., Jacobs H.S. The practical value of the progestogen challenge test, serum estradiol estimation or clinical examination in assessment of the estrogen state and response to clomiphene in amenorrhea. Br J Obstet Gynecol 1979, 86:799.
61. Turksoy R.N., Biller B.J., Farber M., et al. Ovulatory response to clomiphene citrate during bromocriptine failed ovulation in amenorrhea, galactorrhea and hyperprolactinemia. Fertil Steril 1982, 37:441.
62. Wu C.H., Winkel C.A. The effect of therapy initiation day on clomiphene citrate therapy. Fertil Steril 1989, 52:564.
63. Gysler M., March C.M., Mishell D.R., Bailey E.J. A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril 1982, 37:161.
64. O'Herlihy C., Pepperell R.J., Brown J.B., et al. Incremental clomiphene therapy: a new method for treating persistent anovulation. Obstet Gynecol 1981, 58:535.
65. Hammond M.G., Halme J.K., Talbert L.M. Factors affecting the pregnancy rate in clomiphene citrate induction in ovulation. Obstet Gynecol 1983, 62:196.
66. Imani B., Eijkemans M.J.C., te Velde E.R., et al. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligomenorrheic infertility. Fertil Steril 2002, 77:91.
67. Rossing M.A., Daling J.R., Weiss N.S., et al. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994, 331:771.
68. Whittemore A.S., Harris P., Itnyre J. The collaborative ovarian cancer group: collaborative analysis of twelve U.S. case control studies. II. Invasive epithelial cancer in white women. Am J Epidemiol 1992, 136:1184.
69. Cramer D.W., Hutchinson G.B., Welch W.R., et al. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst 1983, 71:711.
70. Mosgaard B.J., Schou G., Lidegaard O., et al. Infertility, infertility drugs and invasive ovarian cancer: a case-control study. Fertil Steril 1997, 67:1005.
71. Potashnik G., Lerner-Geva L., Genkin L., et al. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 1999, 71:853.
72. Dor J., Lerner-Geva L., Rabinovici J., et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002, 77:324.
73. Capelo F.O., Kumar A., Steinkampf M.P., Azziz R. Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrate 2003, 80:1450.
74. Swyer G.I., Radwanska E., McGarrigle H.H. Plasma estradiol and progesterone estimation for the monitoring of induction of ovulation with clomiphene and chorionic gonadotropin. Br J Obstet Gynecol 1975, 82:794.
75. Kosmas I.P., Tatsioni A., Fatemi H.M., et al. Human chorionic gonadotropin administration versus luteinizing hormone monitoring for intrauterine insemination timing after administration of clomiphene citrate. Fertil Steril 2007, 87:607.
76. O'Herlihy C., Pepperell R.J., Robinson H.P. Ultrasound timing of human chorionic gonadotropin administration in clomiphene-stimulated cycles. Obstet Gynecol 1982, 59:40.
77. Zreik T.G., Garcia-Velasco J.A., Haboosh M.S., et al. Prospective randomized crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citrate-stimulated treatment cycles. Fertil Steril 1999, 71:1070.
78. Palopoli F.P., Feil V.J., Allen R.E., et al. Substituted aminoalkoxytriaryl-hodoethylenes. J Med Chem 1967, 10:84.
79. Merrell Dow Pharmaceuticals. Product information bulletin 1972, National Laboratories, Cincinnati, OH.
80. Rein M., Barbieri R.L., Greene M. High order multiple gestation associated with the use of clomiphene and human menopausal gonadotropin. Int J Fertil 1990, 35:154.
81. Saketos M., Sharma N., Santoro N.F. Suppression of hypothalamic-pituitary-ovarian axis in normal women by glucocorticoids. Biol Reprod 1993, 49:1270.
82. Ho Y.B., Mincey E.K. Role of androgens in menstrual disorders of nonhirsute and hirsute women and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women. Am J Obstet Gynecol 1983, 145:152.
83. Daly D.C., Walters C.A., Soto-Albors C.E., et al. A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril 1984, 41:844.
84. Parsanezhad E.M., Alborzi S., Motazedian S., Omrani G. Use of dexamethasone and clomiphene citrate in the treatment of clomiphene-resistant patients with PCOS and normal DHEAS levels. Fertil Steril 2002, 78:1001.
85. Branigan E.F., Estes M.A. Treatment of chronic anovulation resistant to clomiphene by using oral contraceptive ovarian suppression followed by repeat clomiphene treatment. Fertil Steril 1999, 71:544.
86. Branigan E.F., Estes M.A. A randomized clinical trial of treatment of clomiphene resistant anovulation with the use of oral contraceptive pill suppression and repeat clomiphene citrate treatment. Am J Obstet Gynecol 2003, 188:1424.
87. Kistner RW Sequential use of clomiphene citrate and human menopausal gonadotropin in ovulation induction. Fertil Steril 1976, 27:72.
88. Jarrell J., Mclnnes R., Crooke R. Observations on the combination of clomiphene citrate-hMG-hCG in the management of anovulation. Fertil Steril 1981, 35:634.
89. Elkind-Hirsch K.E., Phillips K., Bello S.M., et al. Sequential hormonal supplementation with vaginal estradiol and progesterone gel corrects the effect of clomiphene on the endometrium in oligo-ovulatory women. Hum Reprod 2002, 17:295.
90. Biljan M.M., Mahutte N.G., Tulandi T., Tan S.L. Prospective randomized double-blind trial of the correlation between time of administration and anti-estrogenic effects of clomiphene on reproductive end organs. Fertil Steril 1999, 71:633.
91. Maruo T., Katayama K., Barnea E.R., Mochizuki M. A role for thyroid hormone in the induction of ovulation and corpus luteum function. Horm Res 1991, 37(Suppl 1):12.
92. Laohaprasitiporn C., Barbieri R.L., Yeh J. Induction of ovulation with the sole use of clomiphene in the late onset 21-hydroxylase deficiency. Gynecol Obstet Invest 1996, 41:224.
93. Jarrell J., McInnes R., Crooke R. Observations on the combination of clomiphene-hMG-hCG in the management of anovulation. Fertil Steril 1981, 35:634.
94. Shaw R.J., Lamia K.A., Vasquez D., et al. The kinase LKB1 mediates glucose homeostatis in liver and therapeutic effects of metformin. Science 2005, 310:1642.
95. Legro R.S., Barnhart H.X., Schlaff W.D., et al. Clomiphene, metformin or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007, 356:551.
96. Palomba S., Orio F., Falbo A., et al. Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2007, 92:3498.
97. AL-Fozan H., AL-Khadouri M., Tan S.L., Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 2004, 82:1561.
98. Mitwally M.F., Biljan M.M., Casper R.F. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005, 192:381.
99. Tulandi T., Martin J., Al-Fadhli R., et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene. Fertil Steril 2006, 85:1761.
100. Azim A., Oktay K. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil Steril 2007, 88:657.
101. Oktay K., Hourvitz A., Sahin G., et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006, 91:3885.
102. Azim A.A., Costantini-Ferrando M., Lostritto K., Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 2007, 92:2197.
103. Gemzell C.A., Diczfalusy E., Tillinger K.G. Clinical effect of human pituitary follicle stimulating hormone. J Clin Endocrinol Metab 1958, 18:1333.
104. Lunenfeld B., Sulimovici S., Rabau E., Eshkol A. L'induction de l'ovulation dans les amenorrhea hypophysaires par un traitement combaine de gonadotropine urinaires menopausiques et de gonadotropines chorionique. CR Soc Fr Gynecol 1962, 35:346.
105. Balen A., Platteau P., Nyboe Anderson A., et al. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility. Hum Reprod 2007, 22:1816.
106. Al-Inany H., Aboulghar M., Mansour R., Serour G. Meta-analysis of recombinant versus urinary-derived FSH: an update. Hum Reprod 2003, 18:305.
107. van Wely M., Bayram N. van der Veen, F. Recombinant FSH in alternative doses versus urinary gonadotropins for ovulation induction in subfertility. Hum Reprod 2003, 18:1143.
108. Bennink H.J.T.C., Fauser B.C.J.M., Out H.J. Recombinant follicle stimulating hormone is more efficient than urinary FSH in women with clomiphene citrate resistant, normogonadotropic chronic anovulation. Fertil Steril 1998, 69:19.
109. Lunenfeld B., Eshkol A. Induction of ovulation with gonadotropin. Follicular Maturation and Ovulation 1982, p 361. Exerpta Medica, Amsterdam. R. Rolland, E.V. van Hall, S.G. Hillier (Eds.).
110. Gemzell C.A. Experience with the induction of ovulation. J Reprod Med 1978, 21:205.
111. Schwartz M., Jewelewicz R., Dyrenfurth I., et al. Use of hMG/hCG for induction of ovulation: sixteen years experience at Sloan Hospital for Women. Am J Obstet Gynecol 1980, 138:801.
112. Grazi R.V., Taney F.H., Gagliardi L.L. The luteal phase during gonadotropin therapy: effect of two human chorionic gonadotropin regimens. Fertil Steril 1991, 55:1088.
113. Messinis I.E., Bergh T., Wide L. The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility. Fertil Steril 1988, 50:31.
114. Leader M.D. Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low-dose step-up protocol with weekly increments of 25 IU of FSH. Fertil Steril 2006, 85:1766.
115. Homburg R., Levy T., Ben Rafael Z. A comparative study of conventional regimen with low dose FSH for ovulation in PCOS. Fertil Steril 1995, 63:729.
116. Hedon B., Hugues J.N., Emperaire J.C., et al. A comparative study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women. Hum Reprod 1998, 13:2688.
117. Buyalos R.P., Lee C.T. Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization. Fertil Steril 1996, 65:1.
118. Wada I., Matson P.L., Troup S.A., Lieberman B.A. Assisted conception using buserelin and human menopausal gonadotropins in women with polycystic ovary syndrome. Br J Obstet Gynecol 1993, 100:3665.
119. Devroey P., Fauser B.C., Platteau P., et al. Induction of multiple follicular development by a single dose of long-acting recombinant FSH for controlled ovarian stimulation before IVF. J Clin Endocrinol Metab 2004, 89:2062.
120. Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 2002, 77:1170.
121. De Placido G., Alviggi C., Perino A., et al. Recombinant human LH supplementation versus recombinant human FSH step-up protocol during controlled ovarian stimulation. Hum Reprod 2005, 20:390.
122. Loumay E., Engrand P., Shoham Z., et al. Clinical evidence for an LH ceiling effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in WHO Group I and II anovulation. Hum Reprod 2003, 18:314.
123. Karnitis V.J., Townson D.H., Friedman C.I., Danforth D.R. Recombinant human follicle stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin releasing hormone antagonist treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis. J Clin Endocrinol Metab 1994, 79:91.
124. The Ganirelix Dose Finding Study Group A double-blind randomized dose-finding study to assess the efficacy of the gonadotropin-releasing hormone antagonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle-stimulating hormone. Hum Reprod 1998, 13:3023.
125. Sills E.S., Levy D.P., Moomjy M., et al. A prospective randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization. Hum Reprod 1999, 14:2230.
126. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle stimulating hormone (FSH) induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 1998, 83:1507.
127. Filicori M., Cognigni G.E., Taraborrelli S., et al. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 1999, 84:2659.
128. Hugues J.N., Soussis J., Calderon I., et al. Does addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles. Hum Reprod 2005, 20:629.
129. Lanzone A., Fulghesu A.M., Spina M.A., et al. Successful induction of ovulation and conception with combined gonadotropin releasing hormone agonist plus highly purified follicle stimulating hormone in patients with polycystic ovarian disease. J Clin Endocrinol Metab 1987, 65:1253.
130. Dodson W.C., Hughes C.L., Whiteside D.B., Haney A.F. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 1987, 65:95.
131. Lidor AL Goldenberg M., Cohen S.B., et al. Management of women with polycystic ovary syndrome who experienced premature luteinization during clomiphene citrate treatment. Fertil Steril 2000, 74:749.
132. Homburg R., Levy T., Berkovitz D., et al. Gonadotropin releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril 1993, 59:527.
133. Homburg R., West C., Torresani T., Jacobs H.S. Cotreatment with human growth hormone and gonadotropins for induction of ovulation: a controlled clinical trial. Fertil Steril 1990, 53:254.
134. Whelan J.G., Vlahos N.F. The ovarian hyperstimulation syndrome. Fertil Steril 2000, 73:883.
135. Schenker J.G., Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978, 30:255.
136. Haning R.V., Austin C.W., Carlson I.H., et al. Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fertil Steril 1983, 40:31.
137. Navot D., Relou A., Birkenfeld A., et al. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1988, 159:210.
138. Antman A.M., Politch J.A., Ginsburg E.S. Conversion of high-response gonadotropin intrauterine insemination cycles to in vitro fertilization results in excellent ongoing pregnancy rates. Fertil Steril 2002, 77:715.
139. Shoham Z., Weissman A., Barash A., et al. Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program. Fertil Steril 1994, 62:137.
140. Alvarez C., Marti-Bonmati L., Novella-Maestre E., et al. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 2007, 92:2931.
141. Gonen Y., Balakier H., Powell W., Casper R.F. Use of gonadotropin releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab 1990, 71:918.
142. Emperaire J.C., Ruffie A. Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome. Hum Reprod 1991, 6:506.
143. Lanzone A., Fulghesu A.M., Villa P., et al. Gonadotropin releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles. Fertil Steril 1994, 62:35.
144. Felemban A., Tan S.L., Tulandi T. Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal. Fertil Steril 2000, 73:266.
145. Amer S.A.K., Li T.C., Cooke I.D. A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy. Hum Reprod 2003, 18:1693.
146. Abdel Gadir A., Mowafi R.S., Alnaser H.M., et al. Ovarian electro-cautery versus human menopausal gonadotropins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin Endocrinol 1990, 33:585.
147. Farquhar C.M., Williamson K., Gudex G., et al. A randomized controlled trial of laparoscopic ovarian diatherym versus gonadotropin therapy for women with clomiphene resistant polycystic ovary syndrome. Fertil Steril 2002, 78:404.
148. Bayram N., Van Wely M., van der Veen F., Bossuyt P.M.M. Treatment preferences and trade-offs for ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 2005, 84:420.
149. Farquhar C.M., Williamson K., Brown P.M., Garland J. An economic evaluation of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate resistant polycystic ovary syndrome. Hum Reprod 2004, 19:1110.
150. Pirwany I., Tulandi T. Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure. Fertil Steril 2003, 80:241.
151. Santoro N., Wierman M.E., Filicori M., et al. Intravenous administration of pulsatile gonadotropin releasing hormone in hypothalamic amenorrhea: effects of dosage. J Clin Endocrinol Metab 1986, 62:109.
152. Crowley W.F., McArthur J.W. Stimulation of the normal menstrual cycle in Kallmann's syndrome by pulsatile administration of luteinizing hormone releasing hormone. J Clin Endocrinol Metab 1980, 51:173.
153. Seibel M.M., Kamrava M., McArdle C., Taymor M.L. Ovulation induction and conception using subcutaneous pulsatile luteinizing hormone releasing hormone. Obstet Gynecol 1983, 61:292.
154. Martin K.A., Hall J.E., Adams J.M., Crowley W.F. Comparison of exogenous gonadotropins and pulsatile gonadotropin releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 1993, 77:125.
155. Barbieri R.L., Ryan K.J. Bromocriptine: endocrine pharmacology and therapeutic applications. Fertil Steril 1983, 39:727.
156. Davis O.K., Berkley A.S., Naus G.J., et al. The incidence of luteal phase defect in normal fertile women determined by serial endometrial biopsies. Fertil Steril 1989, 51:582.
157. Murray M.J., Meyer W.R., Zaino R.J., et al. A critical analysis of the accuracy, reproducibility and clinical utility of histological endometrial dating in fertile women. Fertil Steril 2004, 81:1333.
158. Csapo A.I., Pulkkinen M.O., Ruttner B., et al. The significance of the human corpus luteum in pregnancy maintenance. Am J Obstet Gynecol 1972, 112:1061.
159. Richardson S.J., Senikas V., Nelson J.F. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987, 65:1231.
160. Faddy M.J., Gosden R.G. A mathematical model of follicle dynamics in the human ovary. Hum Reprod 1995, 10:770.
161. Schwartz D., Mayaux M.J. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med 1982, 306:404.
162. Toner J.P., Philput C.B., Jones G.S., Muasher S.J. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991, 55:784.
163. Jick H., Porter J., Morrison A.S. Relation between smoking and age of natural menopause. Lancet 1972, 1:1354.
164. Cramer D.W., Barbieri R.L., Xu H., Reichart J.K.V. Determinants of basal follicle stimulating hormone levels in premenopausal women. J Clin Endocrinol Metab 1994, 79:1105.
165. Westhoff C., Murphy P., Heller D. Predictors of ovarian follicle number. Fertil Steril 2000, 74:624.
166. Clark S.T., Radford J.A., Crowther D., et al. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. J Clin Oncol 1995, 13:134.
167. Scott R.T., Leonardi M.R., Hofmann G.E., et al. A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. Obstet Gynecol 1993, 82:539.
168. Sharara F.I., Beaste S.N., Leonardi M.R., et al. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test. Fertil Steril 1994, 62:257.
169. Jain T., Soules M.R., Collins J.A. Comparison of basal follicle stimulating hormone versus the clomiphene challenge test for ovarian reserve screening. Fertil Steril 2004, 82:180.
170. Hall J.E., Welt C.K., Cramer D.W. Inhibin A and B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 1999, 14:409.
171. Marca A.L., Giulini S., Tirelli A., et al. Anti-mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod 2007, 22:766.
172. Seifer D.B., Maclaughlin D.T. Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertil Steril 2007, 88:539.
173. Wallace W.H., Kelsey T.W. Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Hum Reprod 2004, 19:1612.
174. Bancsi L.F., Broekmans F.J.M., Eijkemans M.J.C., et al. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002, 77:328.
175. Hendriks D.J., Mol B.W.J., Bancsi L.F.J., et al. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization. Fertil Steril 2005, 83:291.
176. Haadsma M.L., Bukman A., Groen H., et al. The number of small antral follicles determines the outcome of endocrine ovarian reserve tests in a subfertile population. Hum Reprod 1925, 22:2007.
177. Agarwal S.K., Buyalos R.P., et al. Clomiphene citrate with intrauterine insemination: Is it effective therapy in women above the age of 35 years. Fertil Steril 1996, 65:759.
178. Toner J.P. Age equals egg quality, FSH level equals egg quantity. Fertil Steril 2003, 79:491.
179. Warburton D. Reproductive loss: how much is preventable?. N Engl J Med 1987, 316:158.
180. Society for Assisted Reproductive Technology. Assisted reproductive technology in the United States and Canada: 1993 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 1995, 64:13.
181. Nicosia S., Matus-Ridley M., Meadows A.T. Gonadal effects of cancer therapy in girls. Cancer 1985, 55:2364.
182. Shahin M.S., Puscheck E. Reproductive sequelae of cancer treatment. Obstet Gynecol Clin North Am 1998, 25:423.
183. Feeney D.D., Moore D.H., Look K.Y., et al. The fate of the ovarian after radial hysterectomy and ovarian transposition. Gynecol Oncol 1995, 56:3.
184. Ataya K., Rao L.Y., Lawrence E., Kimmel R. Luteinizing hormone releasing hormone agonist inhibits cyclophosphamide induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 1995, 52:365.
185. Blumenfeld Z., Avivi I., Linn S., et al. Prevention of irreversible chemotherapy induced ovarian damage in young women with lymphoma by a gonadotropin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 1996, 11:1620.
186. Whitehead E., Shalet S.M., Blackledge G., et al. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin disease. Cancer 1983, 52:988.
187. Porcu E., Fabbri R., Damiano G., et al. Clinical experience and applications of oocyte cryopreservation. Mol Cell Endocrinol 2000, 169:33.
188. Chen C. Pregnancy after human oocyte cryopreservation. Lancet 1986, 1:884.
189. Trounson A., Kirby C. Problems in the cryopreservation of unfertilized eggs by slow cooling in dimethyl sulfoxide. Fertil Steril 1989, 52:778.
190. Schnorr J.A., Muasher S.J., Jones H.W. Evaluation of the clinical efficacy of embryo cryopreservation. Mol Cell Endocrinol 2000, 169:85.
191. Oktay K., Newton H., Aubard Y., et al. Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology?. Fertil Steril 1998, 69:1.
192. Radford J.A., Lieberman B.A., Brison D.R., et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin lymphoma. Lancet 2001, 357:1172.
193. Oktay K., Economos K., Kan M., et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA 2001, 286:149.
194. Demeestere I., Simon P., Buxant F., et al. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod 2006, 21:2010.
195. Donnez J., Dolmans M.M., Dermylle D., et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004, 364:1405.
196. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 1917, 318:2007.
197. Salooja N., Szydio R.M., Socie G., et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 2001, 358:271.
198. Westrom L. Incidence prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980, 138:880.
199. Patton D.L., Askienazy-Elbhar M., Henry-Suchet J., et al. Detection of Chlamydia trachomatis in fallopian tube tissue in women with postinfectious tubal infertility. Am J Obstet Gynecol 1994, 171:95.
200. Akande V.A., Hunt L.P., Cahill D.J., et al. Tubal damage in infertile women: prediction using chlamydia serology. Hum Reprod 2003, 18:1841.
201. Hubacer D., Lara-Ricalde R., Taylor D. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001, 345:561.
202. Miller W.C., Ford C.A., Morris M., et al. Prevalence of chlamydia and gonococcal infections among young adults in the United States. JAMA 2004, 291:2229.
203. Mueller B.A., Daling J.R., Moore D.E., et al. Appendectomy and the risk of tubal infertility. N Engl J Med 1986, 315:1506.
204. DeCherney A.H., Mezer H.C. The nature of post tuboplasty pelvic adhesions as determined by early and late laparoscopy. Fertil Steril 1984, 41:643.
205. Diamond M.P., DeCherney A.H. Pathogenesis of adhesion formation/reformation: application to reproductive pelvic surgery. Microsurgery 1987, 8:103.
206. Hellebrekers B.W.J., Trimbos-Kemper T.C.M., Trimbos J.B., et al. Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril 2000, 74:203.
207. Diamond M.P., Linsky C.B., Cunningham T., et al. Synergistic effects of Interceed (TC7) and heparin in reducing adhesion formation in the rabbit uterine horn model. Fertil Steril 1991, 55:389.
208. Boyers S.P., Diamond M.P., DeCherney A.H. Reduction of postoperative pelvic adhesions in the rabbit with Gore-Tex surgical membrane. Fertil Steril 1988, 49:1066.
209. Diamond M.P., Cunningham T., Linsky C.B., et al. Interceed (TC7) as an adjuvant for adhesion prevention: animal studies. Prog Clin Biol Res 1990, 358:131.
210. Nordic Adhesion Prevention Group The efficacy of Interceed for prevention of reformation of postoperative adhesions on ovaries, fallopian tubes and fimbriae in microsurgical operations for fertility: a multicenter study. Fertil Steril 1995, 63:709.
211. Franklin R.R. Reduction of ovarian adhesions by the use of Interceed: Ovarian Adhesions Study Group. Obstet Gynecol 1995, 86:335.
212. Stumpf P.G., March C.M. Febrile morbidity following hysterosalpingography: identification of risk factors and recommendations for prophylaxis. Fertil Steril 1980, 33:487.
213. Watson A., Vanderkerckhove P., Lilford R., et al. A meta analysis of the therapeutic role of oil-soluble contrast media at hysterosalpingography: a surprising result?. Fertil Steril 1994, 61:470.
214. Alper M.M., Garner P.R., Spence J.E.H., Quarrington A.M. Pregnancy rates after hysterosalpingography with oil and water soluble contrast media. Obstet Gynecol 1986, 68:6.
215. de Boer A.D., Vemer H.M., Willemsen W.N., Sanders F.B. Oil or aqueous contrast media for hysterosalpingography: a prospective randomized clinical study. Eur J Obstet Gynecol Reprod Biol 1988, 28:65.
216. Johnson N.P., Farquhar C.M., Hadden W.E., et al. The FLUSH trial-flushing with lipiodol for unexplained subfertility by hysterosalpingography. Hum Reprod 2004, 19:2043.
217. Dlugi A.M., Reddy S., Saleh W.A., et al. Pregnancy rates after operative endoscopic treatment of total or near total distal tubal occlusion. Fertil Steril 1994, 62:913.
218. Canis M., Mage G., Pouly J.L., et al. Laparoscopic distal tuboplasty: report of 87 cases and a 4-year experience. Fertil Steril 1991, 56:616.
219. Schlaff W.D., Hassiakos D.K., Damewood M.D., Rock J.A. Neosalpingostomy for distal tubal obstruction: prognostic factors and impact of surgical technique. Fertil Steril 1990, 54:984.
220. Singhal V., Li T.C., Cooke I.D. An analysis of factors influencing the outcome of 232 consecutive tubal microsurgery cases. Br J Obstet Gynecol 1991, 98:628.
221. Sulak P.J., Letterie G.S., Hayslip C.C., et al. Hysteroscopic cannulation and lavage in the treatment of proximal tubal occlusion. Fertil Steril 1987, 48:493.
222. Thurmond A.S., Burry K.A., Novy M.J. Salpingitis isthmica nodosa: results of transcervical fluoroscopic catheter recanalization. Fertil Steril 1995, 63:715.
223. Silber S.H., Cohen R. Microsurgical reversal of female sterilization: the role of tubal length. Fertil Steril 1980, 33:598.
224. Istre O., Olsboe F., Trolle B. Laparoscopic tubal anastomosis: reversal of sterilization. Acta Obstet Gynecol Scand 1993, 72:680.
225. Camus E., Poncelet C., Goffinet F., et al. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod 1999, 14:1243.
226. Mukherjee T., Copperman A.B., McCafrey C., et al. Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy. Fertil Steril 1996, 66:851.
227. Johnson N.P., Mak W., Sowter M.C. Laparoscopic salpingectomy for women with hydrosalpinges enhances the success of IVF. Hum Reprod 2002, 17:543.
228. Strandell A., Lindhard A., Waldenstrom U., et al. Hydrosalpinx and IVF outcome: a prospective randomized multicenter trial in Scandinavia on salpingectomy prior to IVE. Hum Reprod 1999, 14:2762.
229. Sagoskin A.W., Lessey B.A., Mottla G.L., et al. Salpingectomy or proximal tubal occlusion of unilateral hydrosalpinx increases the potential for spontaneous pregnancy. Hum Reprod 2003, 18:2634.
230. Jette N.T., Glass R.H. Prognostic value of the postcoital test. Fertil Steril 1972, 23:29.
231. Kovacs G.T., Newman G.B., Henson G.L. The postcoital test: what is normal?. BMJ 1978, 23:29.
232. Collins J.A., So Y., Wilson E.H., et al. The postcoital test as a predictor of pregnancy among 355 infertile couples. Fertil Steril 1984, 41:703.
233. Stillman R.J., Miller L.C. Diethylstilbestrol exposure in utero and endometriosis in infertile females. Fertil Steril 1984, 41:369.
234. Samson S.L.A., Bentley J.R., Fahey T.J., et al. The effect of LOOP electrosurgical excision procedure on future pregnancy outcome. Obstet Gynecol 2005, 105:325.
235. Guzick Ds A.J., Barbieri R.L., et al. Heterogeneous cytogenetic abnormalities are associated with uterine leiomyomata. Obstet Gynecol 1991, 77:923.
236. Schoenmakers E.F.P.M., Wanschura S., Mols R., et al. Recurrent rearrangements in the high mobility group protein gene, HMGI-C in benign mesenchymal tumors. Nature Genet 1995, 10:436.
237. Barbieri R.L., Andersen J. Uterine leiomyomata: the somatic mutation theory. Semin Reprod Endocrinol 1992, 10:301.
238. Andersen J., DyReyes V., Barbieri R.L., et al. Leiomyoma primary cultures have elevated transcriptional response to estrogen compared to autologous myometrial cultures. J Soc Gynecol Invest 1995, 2:542.
239. Farhi J., Ashkenazi J., Feldberg D., et al. Effect of uterine leiomyomata on results of IVF treatment. Hum Reprod 1995, 10:2576.
240. Stovall D.W., Parrish S.B., Van Voorhis B.J., et al. Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study. Hum Reprod 1998, 13:192.
241. Surrey E.S., Lietz A.K., Schoolcraft W.B. Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome. Fertil Steril 2001, 75:405.
242. Vercellini P., Maddalena S., De Giorgi O., et al. Abdominal myomectomy for infertility: a comprehensive review. Hum Reprod 1998, 13:873.
243. Exaqcoustos C., Rosati P. Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynecol 1993, 82:97.
244. Rice J.P., Kay H.H., Mahony B.S. The clinical significance of uterine leiomyomata in pregnancy. Am J Obstet Gynecol 1989, 160:1212.
245. Muram D., Gillieson M., Walters J.H. Myomas of the uterus in pregnancy: ultrasonographic follow-up. Am J Obstet Gynecol 1980, 138:16.
246. Clementini E., Palka C., Iezzi I., et al. Prevalence of chromosomal abnormalities in 2078 infertile couples referred for assisted reproductive techniques. Hum Reprod 2005, 20:437.
247. Layman L.C. BMP15-the first true ovarian determinant gene on the X-chromosome. J Clin Endocrinol Metab 2006, 91:1673.
248. Kaufman F.R., Reichardt J.K., Ng W.G., et al. Correlation of cognitive neurologic and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyl transferase gene. J Pediatr 1994, 125:225.
249. Aittomaki K., Dieguez Luccena J.L., Pakarinen P., et al. Mutation in the follicle stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995, 82:959.
250. Toledo S.P., Brunner H.G., Kraaij R., et al. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46XX female. J Clin Endocrinol Metab 1996, 81:3850.
251. Schwartz C.E., Howard-Peebles P.N., Bugge M., et al. Obstetrical and gynecological complications in fragile X carriers. Am J Med Genet 1994, 51:400.
252. Crisponi I., Deiana M., Loi A., et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001, 27:159.
253. Di Pasquale E., Rossetti R., Marozzi A., et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 1976, 91:2006.
254. Christin-Maitre S., Vasseur C., Portnoi M.F., Bouchard P. Genes and premature ovarian failure. Mol Cell Endocrinol 1998, 145:75.
255. Moghissi K.S., Wallach E.E. Unexplained infertility. Fertil Steril 1983, 39:5.
256. Tanahatoe S., Hompes P.G.A., Lambalk C.B. Accuracy of diagnostic laparoscopy in the infertility work-up before intrauterine insemination. Fertil Steril 2003, 79:361.
257. Blacker C.M., Ginsburg K.A., Leach R.E., et al. Unexplained infertility: evaluation of the luteal phase. Fertil Steril 1997, 67:437.
258. Guzick D.S., Carson S.A., Coutifaris C., et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl J Med 1999, 340:177.
259. Hull M.G., Williams J.A., Ray B., et al. The contribution of subtle oocyte or sperm dysfunction affecting fertilization in endometriosis associated or unexplained infertility. Hum Reprod 1825, 13:1998.
260. Hull M.G. Effectiveness of infertility treatments: choice and comparative analysis. Int J Obstet Gynecol 1994, 47:99.
261. Van Voorhis B.J., Stovall D.W., Sparks A.E.T., et al. Cost-effectiveness of infertility treatments: a cohort study. Fertil Steril 1997, 67:830.
262. Hassan M.A.M., Killick S.R. Negative lifestyle is associated with a significant reduction in fecundity. Fertil Steril 2004, 81:384.
263. Barbieri R.L. The initial fertility consultation: recommendations concerning cigarette smoking, body mass index and alcohol and caffeine consumption. Am J Obstet Gynecol 2001, 185:1168.
264. Vatyavanich T., Collins J.A. An overview of the Canadian Infertility Therapy Evaluation study. J Soc Obstet Gynecol Can 1991, 13:29.
265. Hull M.G., Glazener C.M.A., Kelly N.H., et al. Population study of causes, treatment and outcome of infertility. Br Med J 1985, 291:1693.
266. Cooke I.D. Donor insemination-timing and insemination method. 35th Royal College of Obstetricians and Gynecologists Study Group Evidence-Based Fertility Treatment 1998, RCOG Press, London. A. Templeton, I.D. Cooke, P.M.S. O'Brien (Eds.).
267. Ford W.C.L., Mathur R.S., Hull M.G.R. Intrauterine insemination: is it an effective treatment for male factor infertility. Balliere Clin Obstet Gynecol 1997, 11:691.
268. Alborzi S., Motazedian S., Parsanezhad M.E., Jannati S. Comparison of the effectiveness of single IUI versus double IUI in infertile patients. Fertil Steril 2003, 80:595.
269. Saleh A., Tan S.L., Biljan M.M., Tulandi T. A randomized study of the effect of 10 minutes of bed rest after intrauterine insemination. Fertil Steril 2000, 74:509.
270. Cantineau A.E.P., Heineman M.J., Al-Inany H., Cohen B.J. Intrauterine insemination versus fallopian tube sperm perfusion in non-tubal subfertility: a systematic review. Hum Reprod 2004, 19:2721.
271. Hughes E., Collins J., Vandekerckhove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database of Systemic Reviews:CD000057 2000.
272. Glazener C.M., Coulson C., Lambert P.A., et al. Clomiphene treatment for women with unexplained infertility. Gyn Endocrinol 1990, 4:75.
273. Merrill Dow Pharmaceuticals Product information bulletin. Cincinnati, OH, Merril Dow Pharmaceuticals 1972.
274. Deaton J.L., Gibson M., Blackmer K.M., et al. A randomized controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. Fertil Steril 1990, 54:1083.
275. Zreik T.G., Garcia-Velasco J.A., Habboosh M.S., et al. Prospective, randomized crossover study to evaluate the benefit of human chorionic gonadotropin timed versus urinary luteinizing hormone timed intrauterine insemination in clomiphene citrate stimulated cycles. Fertil Steril 1999, 71:1070.
276. Sharara F.I., Beaste S.N., Leonardi M.R., et al. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test. Fertil Steril 1994, 62:257.
277. Agarwal S.K., Buyalos R.P. Clomiphene citrate with intrauterine insemination: is it effective therapy in women above the age of 35 years. Fertil Steril 1996, 65:759.
278. Serhal P.F., Katz M., Little V., Woronowski H. Unexplained infertility: the value of pergonal superovulation combined with intrauterine insemination. Fertil Steril 1988, 49:602.
279. Sher G., Knutzen V.K., Stratton C.J., et al. In vitro sperm capacitation and transcervical intrauterine insemination for the treatment of refractory infertility. Fertil Steril 1984, 41:260.
280. Dodson W.C., Whiteside D.B., Hughes C.L., et al. Superovulation with intrauterine insemination in the treatment of infertility. Fertil Steril 1987, 48:441.
281. Stewart J.A. Stimulated IUI is not a natural choice for the treatment of unexplained infertility. Hum Reprod 2003, 18:903.
282. van Rumste M.M.E., den Hartog J.E., Dumoulin J.C.M., Evers J.L.H., Land J.A. Is controlled ovarian stimulation in intrauterine insemination an acceptable therapy in couples with unexplained non-conception in the perspective of multiple pregnancies?. Hum Reprod 2006, 21:701.
283. Steure P., van der Steeg J.W., Hompes P.G.A., et al. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomized clinical trial. Lancet 2006, 368:216.
284. Reindollar R.H., Regan M.M., Neumann P.J., et al. A randomized controlled trial of 503 couples assigned to conventional infertility treatment or an accelerated track to IVF. Fertil Steril 2007, 88(Suppl 1):S41.
285. Sengoku K., Tamate K., Takaoka Y., et al. A randomized prospective study of gonadotropin with or without gonadotropin releasing hormone agonist for treatment of unexplained infertility. Hum Reprod 1994, 9:1043.
286. Goverde A.J., McDonnell J., Vermeiden J.P.W., et al. Intrauterine insemination or in-vitro fertilization in idiopathic subfertility and male sub-fertility: a randomized trial and cost-effectiveness analysis. Lancet 2000, 355:13.
287. Soliman S., Daya S., Collins J., Jarrel J. A randomized clinical of in vitro fertilization versus conventional treatment for infertility. Fertil Steril 1993, 59:1239.
288. Aboulghar M.A., Mansour R.T., Serour G.I., et al. Management of long standing unexplained infertility: a prospective study. Am J Obstet Gynecol 1999, 181:371.
289. Gurgan T., Urman B., Yarali H., Kisnisci H.A. The results of in vitro fertilization embryo transfer in couples with unexplained infertility failing to conceive with Superovulation and intrauterine insemination. Fertil Steril 1995, 64:93.
290. Guzick D.S., Overstreet J.W., Factor-Litvak P., et al. Sperm morphology, motility and concentration in fertile and infertile men. N Engl J Med 2001, 345:1388.
291. Stillman R.J., Rosenberg M.J., Sachs B.P. Smoking and reproduction. Fertil Steril 1986, 46:545.
292. Phipps W.R., Cramer D.W., Schiff I., et al. The association between smoking and female infertility as influenced by cause of the infertility. Fertil Steril 1987, 48:377.
293. Bouyer J., Coste J., Fernandez H., Job-Spira N. Tobacco and ectopic pregnancy. Rev Epidemiol Sante Publique 1998, 46:93.
294. Matikainen T., Perez G.I., Jurisicova A., et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nature Genet 2001, 28:355.
295. Howe G., Westhoff C., Vessey M., Yeates D. Effects of age, cigarette smoking and other factors on fertility: findings in a large prospective study. Br Med J Clin Res Ed 1985, 290:1697.
296. Bolumar F., Olsen J., Boldsen J. Smoking reduces fecundity: a European multicenter study on infertility and subfecundity (The European Study Group on Infertility and Subfecundity). Am J Epidemiol 1996, 143:578.
297. Grodstein F., Goldman M.B., Ryan L., Cramer D.W. Relation of female infertility to consumption of caffeinated beverages. Am J Epidemiol 1993, 137:1353.
298. Bolumar F., Olsen J., Rebagliato M., Bisanti L. Caffeine intake and delayed conception: a European multicenter study on infertility and subfecundity. Am J Epidemiol 1997, 145:324.
299. Stanton C.K., Gray R.H. Effects of caffeine consumption on delayed conception. Am J Epidemiol 1995, 142:1322.
300. Cnattingius S., Signorello L.B., Anneren G., et al. Caffeine intake and the risk of first-trimester spontaneous abortion. N Engl J Med 1839, 343:2000.
301. Kucheria K., Saxena R., Mohan D. Semen analysis in alcohol dependence syndrome. Andrologia 1985, 17:558.
302. Nagy F., Pendergrass P.B., Bowen D.C., et al. A comparative study of cytological and physiological parameters of semen obtained from alcoholics and non-alcoholics. Alcohol 1986, 21:17.
303. Grodstein F., Goldman M.B., Cramer D.W. Infertility in women and moderate alcohol use. Am J Public Health 1994, 4:1429.
304. Jensen T.K., Hjollund N.H., Henriksen T.B., et al. Does moderate alcohol consumption affect fertility? Follow-up study among couples planning first pregnancy. BMJ 1998, 317:505.
305. Hakim R.B., Gray R.H., Zacur H. Alcohol and caffeine consumption and decreased fertility. Fertil Steril 1998, 70:632.
306. Juhl M., Andersen A.N., Gronbaek M., Olsen J. Moderate alcohol consumption and waiting time to pregnancy. Hum Reprod 2002, 16:2705.
307. Campagne D.M. Should fertilization treatment start with reducing stress. Hum Reprod 2006, 21:1651.
308. Klonoff-Cohen H., Chu E., Natarajan L., Sieber W. A prospective study of stress among women undergoing in vitro fertilization or gamete intrafallopian tube transfer. Fertil Steril 2001, 76:675.
309. Domar A.D., Clapp D., Slawsby E.A., et al. Impact of group psychological interventions on pregnancy rates in infertile women. Fertil Steril 2000, 73:805.
310. Seibel M.M., Levin S. A new era in reproduction technologies: the emotional stages of in vitro fertilization. J In. Vitro Pert Embryo Transf 1987, 4:135.
311. Wasser S.K., Sewall G., Soules M.R. Psychosocial stress as a cause of infertility. Fertil Steril 1993, 59:685.
312. Menning B.E. The emotional needs of infertile couples. Fertil Steril 1980, 34:313.
313. Freeman W.E., Rickels K., Tausig J., et al. Emotional and psychosocial factors in follow-up of women after IVF-ET treatment: a pilot investigation. Acta Obstet Gynecol Scand 1987, 66:517.
314. Redshaw M., Hockly C., Davidson L.L. A qualitative study of the experience of treatment for infertility among women who successfully became pregnant. Hum Reprod 2007, 22:295.
315. Schmidt L., Holstein B.E., Boivin J., et al. High ratings of satisfaction with fertility treatment are common. Hum Reprod 2003, 18:2638.
316. Coutifaris C., Myers E.R., Guzick D.S., et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 2004, 82:1264.
317. Guzick D.S., Overstreet J.W., Factor-Litvak P., et al. Sperm morphology, motility and concentration in fertile and infertile men. N Engl J Med 2001, 345:1388.
318. Holzer H., Casper R., Tulandi T. A new era in ovulation induction. Fertil Steril 2006, 85:277.
319. Layman L.C. BMP15-the first true ovarian determinant gene on the X-chromosome. J Clin Endocrinol Metab 2006, 91:1673.
320. Legro R.S., Barnhart H.X., Schlaff W.D., et al. Clomiphene, metformin or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007, 356:551.
321. Lobo R.A. Potential options for preservation of fertility in women. N Engl J Med 2005, 353:64.
322. Schlechte J.A. Prolactinoma. N Engl J Med 2003, 349:2035.
323. Wittenberger M.D., Hagerman R.J., Sherman S.L., et al. The FMR1 premutation and reproduction. Fertil Steril 2007, 87:456.